Correction: b5, g3, e1 information, f10/h6: medical device problem codes and component codes (add codes), and h4.B5: additionally, it was reported that the packaging (overpouch) of the two (2) minicaps was also opened (previously omitted in the initial report).E1: initial reporter address: (b)(6).G3: the previous date should have been july 31, 2022 (not august 03, 2022).H10: the actual devices were not available; however, photographs of the samples were provided for evaluation.A visual inspection of the photos identified two (2) packages that were opened.However, the characteristic mark of having formed a seal between the formable paper and the printed paper was present; both identified the fingerprint of the adhesive that was white which indicates the seal of the package was complete when it was released.Another photo identified a minicap with a yellowish coloration inside the sponge which is characteristic of the absorption of iodopovidone; during the manufacturing process, the sponge is white.The amount of iodopovidone could not be verified.Therefore, the reported condition of no iodine could not be verified.The reported condition of opened packaging was verified.The cause of the opened packaging could not be determined.Fourteen (14) retained samples were also evaluated.Visual inspection did not identify any abnormalities that could have contributed to the reported condition.The reported condition was not verified on the retained samples.A batch review was conducted and there were no deviations found related to this reported condition during the manufacture of this lot.Should additional relevant information become available, a supplemental report will be submitted.
|